BioSpace News Archive

Biotech Bay

Data Presented at ASCO Shows Natera’s Signatera Test Detects Immunotherapy Treatment Response in Metastatic Cancers

Results Support Use of New Blood Test as Surrogate Endpoint in Clinical Trials Assessing Immune Checkpoint Inhibitor Effectiveness

June 3, 2019
·
7 min read
Genetown

T1D Exchange Launches Online Registry to Drive Type 1 Diabetes Research

Creating most comprehensive and cohesive body of clinical, health and demographic data to develop accurate snapshot of the national type 1 diabetes community

June 3, 2019
·
3 min read
Biotech Bay

Invitae introduces new service to make it easier for consumers to receive the medical genetic testing that experts trust

Invitae, a leader in medical genetics, announced the availability of its new service for consumers, which makes it easier for consumers to order and receive the same high-quality, medical genetic testing from Invitae that experts use and trust.

June 3, 2019
·
7 min read
Business

FSD Pharma Names Raza Bokhari, M.D. as Permanent CEO

The Board of Directors of FSD Pharma Inc. unanimously voted Raza Bokhari, M.D., Executive Co-Chairman of the Board, as permanent Chief Executive Officer.

June 3, 2019
·
4 min read
Transforming Procurement Process Can Help Medical Devices Manufacturers Achieve Cost Savings | SpendEdge’s Latest Success Story Reveals How

SpendEdge, a leading provider of procurement market intelligence solutions, has announced the completion of their procurement market intelligence engagement for a medical devices company.

June 3, 2019
·
3 min read
Drug Development

Seattle Genetics and Astellas Announce Antibody-Drug Conjugate Enfortumab Vedotin Produced Tumor Response Rate of 44 Percent in Patients with Most Common Type of Advanced Urothelial (Bladder) Cancer

Seattle Genetics, Inc. and Astellas Pharma Inc. announced that data from the first cohort of a pivotal phase 2 clinical trial known as EV-201 demonstrated that the investigational agent enfortumab vedotin rapidly shrank tumors in most patients, resulting in an objective response rate of 44 percent.

June 3, 2019
·
11 min read
Drug Development

NeuroRX to Present Phase 2 Efficacy Data for NRX-101 at 2019 BIO International Convention

First drug targeting suicidal bipolar depression, awarded FDA Breakthrough Therapy Designation

June 3, 2019
·
3 min read
Business

William Shatner Announced as SoClean Spokesperson and Ambassador

Actor and Comedian Will Help the Company Behind the Groundbreaking CPAP Cleaner Advance Its Mission to Improve Lives of Sleep Apnea Sufferers Worldwide

June 3, 2019
·
2 min read
Business

PolarityTE Creates Office of the Chief Executive to Focus on Commercialization and Operational Performance

PolarityTE, Inc. announced that the Board of Directors has created the Office of the Chief Executive, consisting of a team of three senior executives who will focus and collaborate on commercialization, operational and financial performance, and new product development.

June 3, 2019
·
5 min read
Business

New Mass Spectrometer Maximizes Research Insights and Productivity Through Intelligent Data Acquisition Strategies

Thermo Scientific Orbitrap Eclipse Tribrid Mass Spectrometer reinvigorates high-end protein research with expanded analysis capabilities

June 3, 2019
·
5 min read